Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7
- PMID: 33619243
- PMCID: PMC7897876
- DOI: 10.1038/s41392-021-00497-4
Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7
Conflict of interest statement
The authors declare no competing interests.
Figures

Comment on
-
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.Nat Rev Immunol. 2020 Jun;20(6):355-362. doi: 10.1038/s41577-020-0331-4. Epub 2020 May 6. Nat Rev Immunol. 2020. PMID: 32376901 Free PMC article. Review.
Similar articles
-
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.PLoS Pathog. 2020 Dec 16;16(12):e1009127. doi: 10.1371/journal.ppat.1009127. eCollection 2020 Dec. PLoS Pathog. 2020. PMID: 33326472 Free PMC article.
-
Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.J Infect Dis. 2020 Aug 4;222(5):734-745. doi: 10.1093/infdis/jiaa356. J Infect Dis. 2020. PMID: 32563187 Free PMC article.
-
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.J Biol Regul Homeost Agents. 2020 Sep-Oct,;34(5):1629-1632. doi: 10.23812/20-2EDIT. J Biol Regul Homeost Agents. 2020. PMID: 32945158
-
The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response.Biochimie. 2021 Jan;180:169-177. doi: 10.1016/j.biochi.2020.11.010. Epub 2020 Nov 12. Biochimie. 2021. PMID: 33189832 Free PMC article. Review.
-
Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?Cytokine Growth Factor Rev. 2020 Jun;53:63-65. doi: 10.1016/j.cytogfr.2020.05.008. Epub 2020 May 20. Cytokine Growth Factor Rev. 2020. PMID: 32467020 Free PMC article. Review. No abstract available.
Cited by
-
Acellular Human Amniotic Fluid-Derived Extracellular Vesicles as Novel Anti-Inflammatory Therapeutics against SARS-CoV-2 Infection.Viruses. 2024 Feb 9;16(2):273. doi: 10.3390/v16020273. Viruses. 2024. PMID: 38400048 Free PMC article.
-
Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19.RNA Biol. 2022 Jan;19(1):963-979. doi: 10.1080/15476286.2022.2100629. RNA Biol. 2022. PMID: 35938548 Free PMC article.
-
Micro-Players of Great Significance-Host microRNA Signature in Viral Infections in Humans and Animals.Int J Mol Sci. 2022 Sep 11;23(18):10536. doi: 10.3390/ijms231810536. Int J Mol Sci. 2022. PMID: 36142450 Free PMC article. Review.
-
Salivary miRNA Profiles in COVID-19 Patients with Different Disease Severities.Int J Mol Sci. 2023 Jul 1;24(13):10992. doi: 10.3390/ijms241310992. Int J Mol Sci. 2023. PMID: 37446170 Free PMC article.
-
Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects.Viruses. 2023 Feb 27;15(3):641. doi: 10.3390/v15030641. Viruses. 2023. PMID: 36992350 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
- 2019M653170/China Postdoctoral Science Foundation
- 21701194/National Natural Science Foundation of China (National Science Foundation of China)
- 81870506/National Natural Science Foundation of China (National Science Foundation of China)
- 8201101103/National Natural Science Foundation of China (National Science Foundation of China)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous